Bluejay Diagnostics, Inc. Accrued Employee Benefits, Current
Bluejay Diagnostics, Inc. (BJDX) had Accrued Employee Benefits, Current of $264.51 thousand as of 2025-09-30, per its 10-Q filed 2025-11-07.
Financial Statements › Notes › Payables and Accruals › Accrued Liabilities, Current
us-gaap:AccruedEmployeeBenefitsCurrent · last filed 2025-11-07
- 2025-09-30: Accrued Employee Benefits, Current $264.51K.
- 2025-06-30: Accrued Employee Benefits, Current $164.63K.
- 2025-03-31: Accrued Employee Benefits, Current $180.89K.
- 2024-12-31: Accrued Employee Benefits, Current $191.67K.
| Period end | Accrued Employee Benefits, Current |
|---|---|
| 2025-09-30 | $264.51K 10-Q · filed 2025-11-07 |
| 2025-06-30 | $164.63K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $180.89K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $191.67K 10-Q · filed 2025-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |